Management: Follow a balanced, diabetes-friendly diet and limit intake of high-sugar foods
Side Effects and Safety: What to Expect Both semaglutide and tirzepatide share common GLP-1 class side effects, primarily gastrointestinal: nausea, vomiting, diarrhea, or constipation that typically emerge during dose escalation and diminish as your body adjusts
To be eligible for Wegovy, a person must have a body mass index (BMI) of: 30 or higher (obesity), or 27 or higher (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
***Processing times 1-3 weeks Compounded & Name Brand available Additional Medications Sublingual (oral tablets) Semaglutide& Tirzepatide are still available with current processing times 2-3 days
Cell Probes 30 , 386396 (2016)
is supported by a Methusalem grant from KULeuven